1. Koo HS, Son HC, Lee HS, Goong HJ, Kim JS, Kim KB, et al. Survey-based analysis of the clinical treatment status of irritable bowel syndrome in Korea. J Korean Med Sci. 2023; 38(16):e126. PMID:
37096309.
2. Jung KW, Myung SJ. An Asian perspective on irritable bowel syndrome. Intest Res. 2023; 21(2):189–195. PMID:
35645323.
3. Kim YS. Current status of diagnosis and treatment of irritable bowel syndrome in Korea. J Korean Med Sci. 2023; 38(16):e113. PMID:
37096306.
4. Zamani M, Alizadeh-Tabari S, Zamani V. Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2019; 50(2):132–143. PMID:
31157418.
5. Weerts ZZRM, Vork L, Mujagic Z, Keszthelyi D, Hesselink MAM, Kruimel J, et al. Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2019; 31(8):e13629. PMID:
31119844.
6. Meringer H, Mehandru S. Gastrointestinal post-acute COVID-19 syndrome. Nat Rev Gastroenterol Hepatol. 2022; 19(6):345–346. PMID:
35383321.
7. Staudacher HM, Black CJ, Teasdale SB, Mikocka-Walus A, Keefer L. Irritable bowel syndrome and mental health comorbidity - approach to multidisciplinary management. Nat Rev Gastroenterol Hepatol. 2023; 20(9):582–596. PMID:
37268741.
8. Na W, Lee Y, Kim H, Kim YS, Sohn C. High-fat foods and FODMAPs containing gluten foods primarily contribute to symptoms of irritable bowel syndrome in Korean adults. Nutrients. 2021; 13(4):1308. PMID:
33920966.
9. Lee HJ, Kim HJ, Kang EH, Jung KW, Myung SJ, Min YW, et al. Self-reported food intolerance in Korean patients with irritable bowel syndrome. J Neurogastroenterol Motil. 2019; 25(2):222–232. PMID:
30827068.
10. Shafiee NH, Razalli NH, Mokhtar NM, Tan E, Ali RAR. An evaluation of dietary adequacy among patients with constipation-predominant irritable bowel syndrome in Malaysia. Intest Res. 2022; 20(1):124–133. PMID:
33472341.